Market Overview The CXC chemokine receptor type 1 market is emerging as targeted immunomodulation opens new therapeutic pathways for inflammatory and oncological conditions. The CXC Chemokine Receptor Type 1 Market is projected to grow through 2030, driven by receptor antagonist development, immuno-oncology application, and precision medicine approaches supporting selective immune cell...